Skip to main content
Swing Capital

Dishman Carbogen Amcis Ltd

NSE: DCAL BSE: 540701

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.[1]

₹186
52W: ₹128 — ₹322
PE 0 · Book ₹253 · -26% vs book
Market Cap₹2,921 Cr
Stock P/E—Price to Earnings
ROCE0.82%Return on Capital
ROE0.28%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Stock is trading at 0.75 times its book value

Weaknesses

  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -7.19% over past five years.
  • −Company has a low return on equity of -1.16% over last 3 years.
  • −Earnings include an other income of Rs.61.2 Cr.
  • −Company has high debtors of 160 days.

Shareholding Pattern

Promoters59.32%
FIIs7.45%
DIIs1.63%
Public31.6%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%
FIIs8.05%8.18%▲0.18.75%▲0.69.49%▲0.79.94%▲0.48.07%▼1.97.66%▼0.47.45%▼0.2
DIIs1.47%1.22%▼0.31.42%▲0.21.26%▼0.21.27%▲0.01.37%▲0.11.27%▼0.11.63%▲0.4
Public31.17%31.29%▲0.130.51%▼0.829.94%▼0.629.48%▼0.531.23%▲1.831.75%▲0.531.6%▼0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales60871111039397106636040
Expenses638410089807486595643
Operating Profit-33121513232134-4
OPM %-5%4%10%14%14%24%19%5%7%-9%
Net Profit-6-18-31-314-13-73-14-23
EPS ₹-0.37-1.16-1.98-0.220.91-0.85-0.470.17-0.87-1.48

AI Insights

Revenue Trend

TTM revenue at ₹269Cr, down 32.8% YoY. OPM at 9%.

Debt Position

Borrowings at ₹682Cr. Debt-to-equity ratio: 0.17x. Healthy balance sheet.

Capex Cycle

CWIP at ₹48Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 1.63% (-1.50pp change). FIIs: 7.45% (-1.45pp change). Promoters hold 59.32%.

Margin & Efficiency

ROCE improving from 0% (Mar 2015) to 1% (Mar 2025). Working capital days: -74.

Recent Announcements